Traders

Decline in volatility drives NYSE Euronext trading volumes lower

NYSE Euronext trading volumes in August 2012 declined year-over-year and month-over-month due to a decrease in volatility compared to August 2011 and the seasonally slower summer period. 

In August 2011, trading volumes benefited from extreme market volatility in the US and Europe.
 
NYSE Euronext global derivatives ADV in August 2012 of 6.4 million contracts decreased 38.4 per cent compared to August 2011 and decreased 8.6 per cent from July 2012 levels.

NYSE Euronext European derivatives products ADV in August 2012 of 3.2 million contracts decreased 27.8 per cent compared to August 2011 and decreased 6.2 per cent from July 2012.

NYSE Euronext US equity options ADV of 3.1 million contracts in August 2012 decreased 46.3 per cent compared to August 2011 levels and decreased 11.4 per cent from July 2012.

NYSE Euronext’s US options exchanges accounted for 24.8 per cent of total US consolidated equity options trading in August 2012, down from 26.4 per cent in August 2011 and down from 25.9 per cent in July 2012.  

NYSE Liffe US ADV of approximately 63,200 contracts decreased 53.9 per cent from 137,100 contracts in August 2011, but increased from 53,400 contracts in July 2012.  

NYSE Euronext European cash products ADV of 1.1 million transactions in August 2012 decreased 50.1 per cent compared to August 2011 and decreased 25.7 per cent from July 2012 levels.      

NYSE Euronext US cash products handled ADV of 1.4 billion shares in August 2012 decreased 54.6 per cent compared to August 2011 and decreased 12.6 per cent compared to July 2012.  NYSE Euronext’s Tape A matched market share in August 2012 was 31.6 per cent, down from 36.2 per cent in August 2011 and down from 32.1 per cent in July 2012.
 
NYSE Euronext European derivatives products ADV in August 2012 of 3.2 million contracts decreased 27.8 per cent compared to August 2011 and decreased 6.2 per cent from July 2012 levels.

The 3.2 million in European derivatives futures and options contracts ADV in August 2012 consisted of 2.2 million contracts executed through the Liffe Connect trading platform and 1.0 million contracts, or 32.3 per cent, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.

Year-to-date, European derivatives products ADV of 3.8 million contracts was 19.5 per cent below prior year levels.  The 3.8 million in futures and options contracts ADV year-to-date consisted of 2.7 million contracts executed through Liffe Connect trading platform and 1.1 million contracts, or 29.6 per cent, executed through Bclear.

Total fixed income products ADV of 1.4 million contracts in August 2012 decreased 44.6 per cent from August 2011 and decreased 20.5 per cent from July 2012. Year-to-date, total fixed income products ADV of 1.8 million contracts was 24.5 per cent below prior year levels.

Total equity products (including Bclear) ADV of 1.7 million contracts in August 2012 decreased 6.4 per cent compared to August 2011, but increased 12.0 per cent from July 2012.  The 1.7 million contracts in equity products ADV in August 2012 consisted of 1.3 million contracts in individual equity products ADV and 0.4 million contracts in equity index products ADV.  The 1.3 million contracts in individual equity products ADV consisted of 1.0 million in futures contracts, which represented a 167.9 per cent increase compared to August 2011 and 0.3 million in options contracts, which represented a 48.3 per cent decrease compared to August 2011.  The average net rate per contract for individual equity futures contracts is significantly lower than other European derivatives products.  Year-to-date, total equity products ADV of 1.9 million contracts was 15.2 per cent below prior year levels.

Total commodities products ADV of approximately 89,000 contracts in August 2012 increased 32.1 per cent compared to August 2011 and decreased 25.0 per cent compared to July 2012.  Year-to-date, total commodities product ADV of 86,000 contracts was 4.2 per cent above prior year levels.  
US Derivatives

NYSE Euronext US equity options ADV of 3.1 million contracts in August 2012 decreased 46.3 per cent compared to August 2011 and decreased 11.4 per cent compared to July 2012.  Year-to-date, US equity options ADV of 3.8 million contracts was 13.6 per cent below prior year levels.  

Total US consolidated equity options ADV decreased 43.0 per cent to 12.4 million contracts in August 2012 compared to August 2011 and decreased 7.6 per cent compared to July 2012.  Year-to-date, US consolidated equity options ADV of 14.8 million contracts was 14.2 per cent below prior year levels.  

NYSE Euronext’s US options exchanges accounted for 24.8 per cent of total US consolidated equity options trading in August 2012, down from 26.4 per cent in August 2011 and down from 25.9 per cent in July 2012.

NYSE Liffe US ADV of approximately 63,200 contracts decreased 53.9 per cent from 137,100 contracts in August 2011, but increased from 53,400 contracts in July 2012.  Year-to-date, US futures and futures options ADV of 77,900 contracts was 6.3 per cent above prior year levels.
 
NYSE Euronext European cash products ADV of 1.1 million transactions in August 2012 decreased 50.1 per cent compared to August 2011 and decreased 25.7 per cent compared to July 2012.

Year-to-date, European cash products ADV of 1.5 million transactions was 10.9 per cent below prior year levels.

NYSE Euronext US cash products handled ADV in August 2012 decreased 54.6 per cent to 1.4 billion shares compared to August 2011 and decreased 12.6 per cent from July 2012.  Year-to-date, US cash products handled ADV was 1.7 billion shares, down 24.6 per cent from prior year levels.   

NYSE Euronext’s Tape A matched market share in August 2012 was 31.6 per cent, down from 36.2 per cent in August 2011 and down from 32.1 per cent in July 2012.

NYSE Euronext US matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 168 million shares in August 2012 decreased 67.6 per cent compared to August 2011 and decreased 13.9 per cent compared to July 2012.

Year-to-date, NYSE Euronext US matched exchange-traded funds ADV of 217 million shares was 30.5 per cent below prior year levels.  

Further reading



Upcoming events

12 hours 58 min from now - London
2 days 12 hours from now - London
1 week 12 hours from now - Rhode Island
1 week 12 hours from now - Rhode Island
1 week 1 day from now - Boston

Upcoming training